Iteos Therapeutics Inc

NASDAQ ITOS

Data sourced from iex and EODHD
Download Data

Iteos Therapeutics Inc Income Statement 2019 - 2024

This table shows the Income Statement for Iteos Therapeutics Inc going from 2019 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Revenue
M 0 -11 0 0 13 54 19 42 153 241 104 0 0 0 0 0 0 0 0 0 -
Cost of Revenue
M 0 0 0 0 0 0 - - - - - - - - - - - - - - -
Gross Profit
M 0 -12 0 0 12 54 19 42 153 241 104 - - - - - - - - - -
Operating Expenses
M 47 29 43 42 37 36 35 38 32 27 25 - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 13 12 13 13 12 11 11 11 11 10 9 15 7 6 5 2 2 2 3 2 2
Research and Development (R&D) Expenses
M 34 28 31 29 26 25 24 27 21 17 16 14 12 9 9 6 6 6 5 4 4
Other Operating Expenses
M 0 -12 0 0 0 0 0 0 0 0 0 - - - - - - - - - -
Costs and Expenses
M 47 37 42 41 36 35 - - - - - - - - - - - - - - -
Operating Income
M -47 -40 -43 -43 -25 17 -15 3 121 214 79 -29 -19 -15 -14 -9 -8 -8 -8 -6 -6
Interest Expense
M - 8 - - -8 4 13 5 2 - - - - - - - - - - - -
Non-operating Income/Expense
M 10 1 1 0 11 5 13 5 -1 10 -8 0 0 0 0 0 1 1 0 -1 1
EBT
M -37 -28 -33 -33 -14 23 -2 8 120 224 72 -26 -14 -15 -11 -7 -5 -5 -7 -6 -4
Income Tax Provision
M 1 2 -1 1 1 2 -3 3 50 39 3 - 0 0 0 0 - 0 0 0 -
Income after Tax
M -38 -31 -32 -34 -16 20 1 6 70 185 70 - -14 -15 -11 -7 - -5 -7 -6 -
Non-Controlling Interest
M - - - 0 0 0 0 0 0 5 0 0 0 0 1 3 1 - 1 1 -
Net Income
M - - - -34 -16 20 1 6 70 185 70 -26 -14 -15 -12 -10 -7 - -8 -7 -5
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 35,843,116.00 35,838,080.00 35,783,160.00 35,768,952.00 35,716,037.00 37,766,507.00 37,655,740.00 37,635,828.00 38,135,957.00 37,482,089.00 37,482,089.00 35,119,952.00 35,086,662.00 24,349,222.00 24,349,222.00 31,748,491.00 31,748,491.00 9,912,494.00 9,912,494.00 9,912,494.00 9,912,494.00
EBITDA
M -47 -37 -42 -41 -24 19 -14 4 122 215 81 -26 -14 -14 -11 -7 -6 -5 -7 -5 -5
Depreciation and Amortization
M 0 0 0 0 1 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -47 -37 -42 -41 -25 17 -15 3 121 214 81 -27 -14 -15 -11 -7 -6 -5 -7 -5 -5
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -3.84 -8.38 3.53 -3.73 -8.35 10.08 149.90 33.36 41.79 17.48 3.83 - -0.01 -0.01 0.07 0.69 - -0.60 -0.42 -1.02 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Gross Profit Margin
% - 102.06 - - 98.22 99.58 100.00 100.00 100.00 100.00 100.00 - - - - - - - - - -
Operating Income Margin
% - 355.18 - - -197.94 32.25 -78.03 7.99 79.21 88.78 76.16 - - - - - - - - - -
Net Income Margin
% - - - - -123.47 37.94 5.09 13.49 45.62 76.87 66.79 - - - - - - - - - -
EBITDA Ratio
% - 327.49 - - -187.61 35.22 -73.39 9.51 79.82 89.24 77.75 - - - - - - - - - -
EBIT Ratio
% - 329.50 - - -197.94 32.25 -78.03 7.99 79.21 89.18 77.58 - - - - - - - - - -
EBT Ratio
% - 249.39 - - -113.95 42.20 -10.19 20.24 78.37 93.16 69.45 - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email